New Zealand on-farm mastitis diagnostics firm taking technology global
Mastaplex has signed up AgriHealth to distribute its point-of-care mastitis diagnostic in New Zealand, with other deals in the pipeline.
Anizome to bridge valley of death between microbiome research and commercialization
The first company focused on a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition has been created.
TyraTech sales climbing as company goes animal health-only
US parasite control company TyraTech has made progress in ramping up its product sales after it decided to focus solely on animal health.
Pet innovation, vaccines help German industry fight stagnating antibiotic sales
A robust market for small animal innovations and vaccines has helped the German animal health industry report 3% growth in the latest financial year.
Latest Articles
Analysis of Elanco's future
Rumor mill spins faster three months before Elanco's future is revealed
With Elanco's date with destiny set for July 24 (the day of Eli Lilly's second-quarter results), the rumors of potential acquirers have ramped up.
Recent Tweets from Animal Pharm
Tweets by animalpharm
Commercial
Boehringer underlines ascent to the top with more-than-doubled annual sales
Boehringer Ingelheim Animal Health has confirmed its rise to become the industry's second-largest player with 2017 sales of €3.9 billion ($4.75 billion).
Latest From Commercial
Eastern European performance hurts Krka in Q1
The animal health division of Slovenian pharmaceutical company Krka returned to a dip in sales during the first quarter of 2018.
Patterson boosts leadership team with senior appointments
US veterinary products distributor Patterson Companies has made two important appointments to enhance its leadership expertise.
New cat virus discovered in Australia
Researchers in Australia have discovered a new potentially fatal virus in cats.
Oasmia spin-off to begin US vet oncology commercialization in H2
Swedish firm Oasmia Pharmaceutical has completed the spin-off of its veterinary oncology business into a US subsidiary called AdvaVet.
Bactana secures significant portion of new equity round
US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.
Researchers move nearer to an effective swine flu vaccine
Researchers in the UK have generated tools that allow scientists to understand a vital area of the pig immune system that was previously inaccessible.
Top Interviews & Analysis
Animal health industry rankings 2017: One big Boehringer-sized change masks ongoing vibrancy across big players
This year's rankings are dominated by the changes brought by Boehringer Ingelheim's acquisition of Merial. However, the fiscal 2017 standings highlight many more trends and movements. Animal Pharm editor Joseph Harvey looks at a largely positive year for the top lines of animal health's leading players.
TwistDx offers RPA as versatile alternative for veterinary diagnostics
It might only be a matter of time before pet food and pet health combine
A modern strategy emerges from Boehringer following actions in vaccines and diagnostics
K-State aims to start global discussion on developing animal health's employees of the future
Products
PerformaNat discusses investment and strategy for feed additives pipeline
German start-up PerformaNat has outlined the next steps for its technology after receiving significant funding and interest from investors.
Latest From Product
Eastern European performance hurts Krka in Q1
The animal health division of Slovenian pharmaceutical company Krka returned to a dip in sales during the first quarter of 2018.
Indianapolis tech firm to introduce 'telepresence' to veterinary sector
Hodei Technology has formed a new division to take its telepresence communications and wearable technologies to the veterinary market.
Neogen adds to equine antiparasitic range
US firm Neogen has added to its equine preventative range with the launch of a new fly protection product.
Hipra launches sea bass vaccine in Turkey
Fish farms in Turkey now have access to a sea bass vaccine produced by Laboratorios Hipra.
Oasmia spin-off to begin US vet oncology commercialization in H2
Swedish firm Oasmia Pharmaceutical has completed the spin-off of its veterinary oncology business into a US subsidiary called AdvaVet.
Bactana secures significant portion of new equity round
US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.
Data Pharm
Zoetis and Ceva build on vaccine intellectual property
Zoetis, Ceva Santé Animale and Bioveta have all made recent patent applications in the area of vaccine technology.
Sectors
Australia: A big country with opportunities for innovators and new products
Although isolated geographically, Australia has an animal health sector hungry for new products. Animal Pharm analyst Malcolm Flanagan talks to Australian industry body head Ben Stapley about his country's prospects for innovation and veterinary product sales.
Latest From Sector
Indianapolis tech firm to introduce 'telepresence' to veterinary sector
Hodei Technology has formed a new division to take its telepresence communications and wearable technologies to the veterinary market.
Oasmia spin-off to begin US vet oncology commercialization in H2
Swedish firm Oasmia Pharmaceutical has completed the spin-off of its veterinary oncology business into a US subsidiary called AdvaVet.
Bactana secures significant portion of new equity round
US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.
Heska enters deal for point-of-care multiplex diagnostics
Heska has partnered with MBio Diagnostics in a deal focused on bringing new point-of-care multiplex testing technology to the animal health sector.
Biovet invests in expanding facilities, diagnostics capabilities
Canadian veterinary diagnostics company Biovet has begun a Can$2.25 million ($1.75 million) expansion of its headquarters, with construction expected to be completed in July.
Merck study shows pet parents ignorant of tick and flea prevention
A new survey in the US shows that pet owners are largely ignorant of flea and tick infestations associated with companion animals.
Latest From Policy & Regulation
Vietnam addresses AMR issues in livestock
Vietnam recently held a workshop with international experts to look into ways the country can tackle emerging problems with antimicrobial resistance (AMR) in livestock and aquaculture.
Venezuela targeted in LatAm push to eradicate FMD
Having battled for years to free themselves of foot-and-mouth disease (FMD), South American countries are joining forces to help remove the virus from its last bastion on the continent – Venezuela.
EU opts for minor adjustment in copper limits for piglet feed
EU member states have finally agreed on the amount of copper that should be allowed in animal feed, opting for only modest reductions from current limits – at least for now.
New Zealand developing M bovis diagnostic test
Following damaging outbreaks of Mycoplasma bovis in New Zealand cattle, the farm-intensive country is developing a new super-fast diagnostic test for the disease.
Global fake veterinary medicines markets seen as high as $2bn
A new report indicates there is a growing world market for illegal animal medicines.
New EU rules on antimicrobials trigger dairy, meat trade ban fears
International meat and dairy traders are fighting to soften the impact of a clause in the EU's forthcoming new veterinary medicines regulation which, if unamended, could completely block imports into the EU from other countries.
Policy & Regulation
Animal Pharm Podcast #8: Roxane Feller reviews a significant year for Europe
In this latest podcast, Animal Pharm editor Joseph Harvey speaks to AnimalhealthEurope's secretary general Roxane Feller about a series of key topics including the impact of Brexit on animal health.
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.